Assisted reproductive technology in Japan: a summary report of 1992-2014 by the Ethics Committee, Japan Society of Obstetrics and Gynecology.

All the procedures that were followed were in accordance with the ethical standards of the responsible committees on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and its later amendments. Informed consent was obtained from all the patients in the study.

This article does not contain any study that was performed by any of the authors that included animal participants.

There were 598 registered ART facilities in 2014 and the ART treatments at all of these facilities were registered. The number of facilities that actually provided ART treatment in 2014 was 574; the number of implemented cycles was zero at 24 facilities. Figure  1 shows the age distribution of the patients for all registered treatment cycles. The total number of registered treatments was 393 745 cycles, of which 66 550 were pregnancy cycles and 46 008 were cycles with a live birth. Compared to the number of registered treatments in 2008 (Figure  2 ), there was a 2.07‐fold increase in the total number of treatments and a 2.25‐fold increase in the number of cycles with a live birth. The age of the patients who receive ART has become markedly higher each year and the most common age of those patients who received ART in 2014 was 40 years. The trend toward an increasing patient age is thought to continue into the future. Figures  3 and 4 show the annual changes in the number of registered cycles and live births since registration began in 1992. The increases in the total number of ART treatments and ART live births are thought to continue for some time into the future. The total number of ART live births that was registered between 1992, the year in which registration began, and 2014 was 431 626. Age distribution of the women who were treated with assisted reproductive technology procedures in Japan in 2014. Adapted from Japan Society of Obstetrics and Gynecology ART Databook 2014 ( https://plaza.umin.ac.jp/~jsog-art/2014data_201609.pdf ) Age distribution of the women who were treated with assisted reproductive technology procedures in Japan in 2008. Adapted from Japan Society of Obstetrics and Gynecology ART Databook 2008 ( https://plaza.umin.ac.jp/~jsog-art/2008data_pdf.pdf ) Number of cycles in each assisted reproductive technology procedure in Japan between 1992 and 2014. Adapted from Japan Society of Obstetrics and Gynecology ART Databook 2014 ( https://plaza.umin.ac.jp/~jsog-art/2014data_201609.pdf ). FET , frozen–thawed embryo transfer; ICSI , intracytoplasmic sperm injection; IVF , in vitro fertilization Number of live births after assisted reproductive technology procedures in Japan between 1992 and 2014. Adapted from Japan Society of Obstetrics and Gynecology ART Databook 2014 ( https://plaza.umin.ac.jp/~jsog-art/2014data_201609.pdf ). FET , frozen–thawed embryo transfer; ICSI , intracytoplasmic sperm injection; IVF , in vitro fertilization Figure  5 shows the outcomes of ART by patient age for all treatment cycles. As the age increases, the success rate decreases and the rate of miscarriage increases. Compared to the 2008 results (Figure  6 ), these outcomes represent a slight increase, but no major change. Rates of pregnancy, live birth, and miscarriage at each age in Japan in 2014. Adapted from Japan Society of Obstetrics and Gynecology ART Databook 2014 ( https://plaza.umin.ac.jp/~jsog-art/2014data_201609.pdf ). ET , embryo transfer Rates of pregnancy, live birth, and miscarriage at each age in Japan in 2008. Adapted from Japan Society of Obstetrics and Gynecology ART Databook 2008 ( https://plaza.umin.ac.jp/~jsog-art/2008data_pdf.pdf ). ET , embryo transfer

There is no conflict of interest regarding the publication of this study.

For all patients who began treatment between January 1 and December 31, 2014, data for all treatment cycles that were performed at all ART treatment facilities nationwide were entered for each treatment cycle by using the online registry system by the end of November, 2015. The contents that were investigated are shown in Tables  1 and 2 . Cycle‐based registry form: clinical outcome of assisted reproductive technology Yes No Unknown Tubal dysfunction Endometriosis Antisperm antibody Male factor Unknown Others ( ) Oocyte cryopreservation (medical indication) Natural CC CC + hMG or FSH hMG or FSH GnRH agonist + hMG or FSH GnRH antagonist + hMG or FSH Others ( ) Hormone replacement cycle Failed Endovaginal ultrasonography Laparoscopy Use of thawed egg or embryo Others ( ) IVF–ET GIFT ICSI IVF‐ET + ICSI Thawed embryo Others ( ) Oocyte cryopreservation (medical indication) Ejaculated sperm TESE Others ( ) Egg (unfertilized) Cleavage embryos Blastocysts ET cancellation Others ( ) Yes No None Progesterone (P) hCG hCG + P Estrogen + P Others ( ) None Bleeding Infection OHSS (more than Stage II) Others ( ) None Clinical pregnancy (Evidence by ultrasound of an intrauterine sac with or without a fetal heart) (Date of embryo transfer [day/month/year]) ※ If check (2. Clinical pregnancy), input the (Data items from pregnancy to delivery) form. Undetermined ※ Reselect (1. None) or (2. Clinical pregnancy) after determined. req, required; ART, assisted reproductive technology; CC, clomiphene citrate; hMG, human menopausal gonadotropin; FSH, follicle‐stimulating hormone; GnRH, gonadotropin‐releasing hormone; IVF–ET, in vitro fertilization–embryo transfer; GIFT, gamete intrafallopian transfer; ICSI, intracytoplasmic sperm injection; TESE, testicular sperm extraction; OHSS, ovarian hyperstimulation syndrome. Cycle‐based registry form: obstetric outcome of pregnancy Miscarriage Ectopic pregnancy Heterotopic pregnancy Elective termination of pregnancy (reason: ) Live birth Stillbirth Selective reduction performed (number of fetus before reduction [ ], number of fetuses after reduction [ ]) Unknown Vaginal delivery Cesarean delivery Vaginal and cesarean delivery Unknown None Yes Unknown req, required.

The Japan Society of Obstetrics and Gynecology (JSOG) implemented a registry report system for the clinical practice of assisted reproductive technology (ART) in 1986. Starting with the report for fiscal year 1989 (The First Report), 1 the JSOG continuously has reported the clinical outcomes of ART. 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 Since 2008, the JSOG has implemented an online cycle‐based registry system (individual surveys). The most recent version of the annual report is 2014 (the period from January 1 to December 31, 2014) that was published previously in Japanese. 25 As Japan has been the largest contributor of ART in terms of the annual amount of practice, herewith is presented the aggregate results for Japan.